Evofosfamide
CAS:918633-87-1
Evofosfamide (TH-302) is a hypoxia-activated prodrug that releases Br-IPM in tumors to cause DNA damage …
Formula:
C9H16Br2N5O4P
Purity:
99.3% - 99.75%
Color and Shape:
Solid
Molecular weight:
449.04
Ref: TM-T3615
1mg | 52.00 € | ||
5mg | 109.00 € | ||
10mg | 150.00 € | ||
25mg | 257.00 € | ||
50mg | 412.00 € | ||
100mg | 634.00 € | ||
500mg | 1,318.00 € | ||
1mL*10mM (DMSO) | 109.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
TH-302
Controlled ProductCAS:918633-87-1
Applications TH-302 is a 2-nitroimidazole triggered hypoxia-activated prodrug (HAP) of bromo-isophosphoramide mustard. Studies have shown …
Formula:
C9H16Br2N5O4P
Color and Shape:
Neat
Molecular weight:
449.04
Ref: TR-T338200
5mg | 397.00 € | ||
10mg | 549.00 € | ||
50mg | 1,508.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
(1-Methyl-2-nitro-1H-imidazol-5-yl)methyl N,N'-bis(2-bromoethyl)phosphorodiamidate
CAS:918633-87-1
Th-302 is a phosphorodiamidate prodrug that is converted to methyl N,N'-bis(2-bromoethyl)phosphorodiamidate (th-302) in the body. …
Formula:
C9H16Br2N5O4P
Purity:
Min. 95%
Molecular weight:
449.04 g/mol
Ref: 3D-TLB63387
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025